Open AccessSmall intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin
Author(s) -
Sergio Peralta,
Carmelo Cottone,
T. Doveri,
Piero Luigi Almasio,
Antonio Craxı̀
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.2628
Subject(s) - rifaximin , small intestinal bacterial overgrowth , irritable bowel syndrome , medicine , lactulose , bloating , gastroenterology , constipation , breath test , abdominal pain , hydrogen breath test , defecation , diarrhea , antibiotics , helicobacter pylori , microbiology and biotechnology , biology
To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO.